HomeNews2All Posts

Verséa™ Biologics at the North American Neuromodulation Society 26th Annual Meeting

Verséa™ Ophthalmics at the Hawaii Eye 2023

Hear from the Experts on New Point-of-Care Testing & Therapeutic Innovations in Eye Care

Verséa™ Ophthalmics – proud sponsor of 2022 CEDARS/ASPENS Annual Meeting

Verséa™ Ophthalmics featured at the Eyes On 2023 Corporate Exhibit Hall Interview series

Verséa™ Ophthalmics President, Dr. Rob Sambursky, interviewed by Ophthalmology Times

Verséa™ Ophthalmics is presenting at the American Academy of Optometry (AAOpt) Meeting 2022

Verséa Holdings, Inc. Launching Verséa AgroTech and its proprietary Extended Shelf-life Packaging System at the IFPA Global Produce & Floral Show

Verséa Holdings, Inc. is Launching Verséa Health and Verséa Easy Lab™ at the NACS Show 2022

Verséa™ Ophthalmics is Launching Novel, Point-of-Care, Tear-Based Diagnostic Test Platform at the AAO 2022

Verséa Donates COVID-19 Test Kits to the University of South Florida (USF), Worth $1.1M

Verséa Searching For Brightest Students and Recent Graduates at the University of Tampa to Join Paid Internship Program

Verséa™ Ophthalmics Signs Exclusive Global Commercialization Agreement With AXIM® Biotechnologies for Distribution and Sales of Novel Ophthalmic Diagnostics Solutions

Sean Fetcho, the co-founder and CEO of Verséa Holdings, Inc. announced as a Tampa Bay Business Journal 40 under 40 honoree

Verséa Holdings, Inc. welcomes Rob Sambursky, MD, as President to lead the company’s expansion into the ophthalmic market

BA.4, BA.5, two new Omicron variants detected in the U.S., could spark another COVID wave

Successful first validation test on VCX™ Discovery Platform at UCSD Biomedical Lab

New Omicron Subvariant BA.2 Concern: More Contagious and Found in 48 States

Cannabinol (CBN) shows unique therapeutic potential in glaucoma

2 new COVID symptoms reported for BA.2 omicron variant

Omicron variants – Statement from the WHO

New Study Identifies Top-Performing Point-of-Care COVID-19 Tests

CareStart EUA Authorization

Subscribe to the Verséa Membership Club

Receive exclusive membership offers, discounts and latest industry insights, free of charge.

Subscribe to the Verséa Membership Club

Receive exclusive membership offers, discounts and latest industry insights, free of charge.

https://i0.wp.com/www.versea.com/wp-content/uploads/2021/02/new_logo.png?fit=1375%2C415&ssl=1

401 S. Florida Ave, Tampa, FL 33602

© 2022 Verséa Health, Inc. All rights reserved.

Explore Verséa

News